LRRC56
Leucine-rich repeat-containing protein 56
Also known as: DKFZp761L1518, DNAAF12, FLJ00101, LRC56_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYG6
- Gene
- LRRC56
- Ensembl
- ENSG00000161328
- Chromosome
- 11
- Canonical length
- 542 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be involved in cell projection organization. Predicted to be located in cilium. Implicated in primary ciliary dyskinesia 39. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
542 residues, UniProt reviewed canonical sequence.
>Q8IYG6|LRRC56
1 MDLGWDRSRG PRRSTSSVRV RELSWQGLHN PCPQSKGPGS QRDRLGEQLV EEYLSPARLQ
61 ALARVDDLRL VRTLEMCVDT REGSLGNFGV HLPNLDQLKL NGSHLGSLRD LGTSLGHLQV
121 LWLARCGLAD LDGIASLPAL KELYASYNNI SDLSPLCLLE QLEVLDLEGN SVEDLGQVRY
181 LQLCPRLAML TLEGNLVCLQ PAPGPTNKVP RGYNYRAEVR KLIPQLQVLD EVPAAHTGPP
241 APPRLSQDWL AVKEAIKKGN GLPPLDCPRG APIRRLDPEL SLPETQSRAS RPWPFSLLVR
301 GGPLPEGLLS EDLAPEDNTS SLTHGAGQVL CGNPTKGLRE RRHQCQAREP PEQLPQHRPG
361 DPAASTSTPE PDPADSSDFL ALAGLRAWRE HGVRPLPYRH PESQQEGAVA PWGPRRVPEE
421 QVHQAEPKTP SSPPSLASEP SGTSSQHLVP SPPKHPRPRD SGSSSPRWST DLQSRGRRLR
481 VLGSWGPGLG DGVAAVPVLR ALEVASRLSP RAQGCPGPKP APDAAARPPR AAELSHPSPV
541 PTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRRC56 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- testis: 21 nTPM
- pituitary gland: 12 nTPM
- basal ganglia: 9 nTPM
- cerebellum: 4.9 nTPM
- fallopian tube: 4.5 nTPM
- amygdala: 4 nTPM
Single-cell type
- late spermatids: 112 nCPM
- early spermatids: 36 nCPM
- late primary spermatocytes: 26 nCPM
- epididymal efferent duct ciliated cells: 17 nCPM
- ependymal cells: 13 nCPM
- tuft cells: 12 nCPM
Immune cell
- T-reg: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- basal ganglia: 3.9 nTPM
- cerebral cortex: 2 nTPM
- choroid plexus: 1.8 nTPM
- thalamus: 1.7 nTPM
- medulla oblongata: 1.6 nTPM
- amygdala: 1.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LRRC56.
Disease | AllUniProt
Conditions LRRC56 is implicated in, by any mechanism.
- Ciliary dyskinesia, primary, 39 (CILD39) MIM:618254
Disease | GeneticClinVar
24 pathogenic / likely-pathogenic of 488 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ciliary dyskinesia, primary, 39
- LRRC56-related disorder
- Kartagener syndrome
- Malignant tumor of urinary bladder
- Respiratory ciliopathies including non-CF bronchiectasis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.88
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Leucine-rich repeat
- Leucine rich repeat 4
- Leucine-rich repeat domain superfamily
- Leucine Rich repeats (2 copies)
- Leucine-rich repeat-containing protein 56
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRRC56 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRRC56 as an antibody target. Whether an autoantibody or antibody against LRRC56 could matter depends on whether native LRRC56 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRRC56 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRRC56 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...